Transcript
WEBVTT
00:00:01.582 --> 00:00:04.107
Welcome to the Dear Menopause podcast.
00:00:04.107 --> 00:00:06.772
I'm Sonya Lovell, your host Now.
00:00:06.772 --> 00:00:11.929
I've been bringing you conversations with amazing menopause experts for over two years now.
00:00:11.929 --> 00:00:21.121
If you have missed any of those conversations, now's the time to go back and listen, and you can always share them with anyone you think needs to hear them.
00:00:21.121 --> 00:00:25.266
This way, more people can find these amazing conversations, needs to hear them.
00:00:25.266 --> 00:00:26.428
This way, more people can find these amazing conversations.
00:00:26.448 --> 00:00:29.931
Welcome to Dear Menopause and this week we have a hot take episode.
00:00:29.931 --> 00:00:31.952
Joining me is my Johanna Wicks.
00:00:31.952 --> 00:00:33.835
Hey, jo, so good to be here again.
00:00:33.835 --> 00:00:34.856
Are you excited?
00:00:34.856 --> 00:00:40.639
I'm very excited.
00:00:40.639 --> 00:00:51.505
As a refresher for anyone that's forgotten because it was a month ago, or for anyone that hasn't listened to a hot take episode previously, joe and I are going to talk about kind of the what's hot in the menopause space in australia right now and globally as well.
00:00:51.505 --> 00:01:03.026
But really focusing on australia, break down what that means for you as a consumer, which is just an awful term you as a woman in australian society that is likely to be impacted by perimenopause and menopause.
00:01:03.026 --> 00:01:28.561
So last episode we finished off talking about the PBS and different HRTs, why they were on the PBS, why they weren't, and we were waiting for an announcement from PBAC, which is the advisory committee deciding which meds do go onto PBS about Prometrium yes and Estrogel Yep and Estrogel Pro yes, which is the two combined as one prescription.
00:01:28.561 --> 00:01:30.364
Okay, jo, tell us what happened.
00:01:31.246 --> 00:01:32.629
So it was very exciting.
00:01:32.629 --> 00:01:46.278
I think the results came out on the 20th of December, so right before Christmas, and obviously there's lots of women, I think, that have been waiting on this outcome because none of these products have been listed on the PBS.
00:01:46.278 --> 00:01:54.990
They're available in the private market but that does mean that they're a bit out of reach for a percentage of the population, which really plays into inequity of healthcare.
00:01:54.990 --> 00:02:14.908
So the Pharmaceutical Benefits Advisory Committee published their results from their November meeting on the 20th of December and the PBAC outcome I'll actually read it out because it's so exciting was the PBAC recommended the listing of Estrogel Metrium and Estrogel Pro as general schedule unrestricted benefit listings.
00:02:14.908 --> 00:02:34.306
The main thing they said this bit really resonated with me was that the PBAC noted consumer comments stating it was important to have a range of MHT options available on the PBS and that these products were effective in managing symptoms of menopause and provided benefits compared to other PBS listed MHT products.
00:02:35.109 --> 00:02:48.906
In the context of limited clinical evidence, the PBAC found the consumer comments particularly useful in articulating patient-relevant outcomes, especially from those people currently supplied these products on the private market.
00:02:49.647 --> 00:02:50.610
This is a great outcome.
00:02:50.610 --> 00:02:55.979
This means that the products move to the next stage of the PBS process, which I'll get to in just a second.
00:02:55.979 --> 00:03:04.811
But I think what's really exciting about that particular comment is it shows how important that we as consumers are when we engage with the healthcare system.
00:03:04.811 --> 00:03:19.894
So as part of the PBS and PBAC process, there is an opportunity for consumers to comment on any drugs that are put up, and obviously you know the pharmaceutical company puts in a massive dossier with all the evidence and why they think it should be on the PBS.
00:03:19.894 --> 00:03:24.939
A lot of doctors will often respond as well and indicate why they think it's important.
00:03:24.939 --> 00:03:26.945
A lot of doctors will often respond as well and indicate why they think it's important.
00:03:26.945 --> 00:03:41.667
But it's the voices of consumers which I think is so critical sometimes in this discussion, because it's those lived experiences of medicines and how they impact us that can often be missed, especially if there isn't a lot of clinical evidence.
00:03:41.907 --> 00:03:42.169
Yeah.
00:03:42.188 --> 00:03:43.132
So what this means.
00:03:43.939 --> 00:03:48.546
That was also so evident, which we've talked about before as a part of the Senate inquiry.
00:03:48.546 --> 00:04:03.788
You know, the senators said when they handed down their report how their findings were so driven by the submissions and the hearings that came from not just the medical profession but from patients and women and consumers themselves.
00:04:03.788 --> 00:04:04.591
So, yeah, huge.
00:04:04.591 --> 00:04:12.223
But one of the things we are going to talk about today is actually how you can be more of an advocate in this space and use your voice.
00:04:12.223 --> 00:04:19.209
So, now that we know that, that was the outcome from PBAC, but there is a next step before we see anything actually added to the PBS.
00:04:19.209 --> 00:04:19.872
Talk us through that.
00:04:20.379 --> 00:04:22.608
Yeah, so what happens now?
00:04:22.827 --> 00:04:28.204
So the first hurdle in terms of this product being listed, has occurred because it's been recommended.
00:04:28.384 --> 00:04:47.043
The second hurdle, which we did talk about in our previous hot take, which is that complicated outcome as to whether or not PBAC recommends that it's compared to the lowest price product that is, similar on the PBS, the lowest cost comparator, or if they're willing to have negotiations with the pharmaceutical company.
00:04:47.064 --> 00:04:58.024
So I think in December we had talked about how there was a recent contraceptive pill which was recommended, but recommended at the lowest cost comparator, which we spoke about in detail.
00:04:58.024 --> 00:05:47.083
Excitingly for these products, for these modern MHT products, they have indicated that they are willing to go into price discussions, and so what that means now is that the Department of Health and the pharmaceutical company who put up the products, which is Besson's, will start a discussion on price, and that can take a couple of months, and what it requires, basically, is it requires the Department of Health and the Australian Health System to recognise that these are modern medicines and that they need to be remunerated in a way that ensures that the producers of the product, you know, are covering their costs and, you know, as a private company, making a profit, making money, but also requires the pharmaceutical company to come to the table and be realistic about what price they can expect this product.
00:05:47.083 --> 00:05:51.413
Yeah, so this is a really exciting outcome it really is.
00:05:52.194 --> 00:06:04.807
Um, you know, I know you and I were both hugely excited on the day when we found on the website pbac website that they, you know made they published the findings that we all dove in there and had a look and then got super excited.
00:06:04.807 --> 00:06:14.711
I got a wonderful email from the team at Beesons that same day acknowledging the work that you know advocates within the community had done to get us to this point.
00:06:14.711 --> 00:06:29.629
So they were incredibly grateful for everything that you know was being done to support their drive for this to happen, but also acknowledging that, yeah, now they're in that step of negotiating on price, which you know is great that they've even opened those doors to do that for us.
00:06:29.629 --> 00:06:30.632
So huge, huge.
00:06:32.382 --> 00:06:34.271
And it actually says in the PBAC document.
00:06:34.271 --> 00:06:42.120
It says the PBAC recommended listing of the three products at a price it considered acceptable in the context of uncertainty in the magnitude of benefits.
00:06:42.120 --> 00:06:44.326
And I just wanted to add a little addition there.
00:06:44.326 --> 00:06:47.836
And, you know, I think maybe we can park this for a hot take next time, sonia.
00:06:47.836 --> 00:07:08.370
This again comes back to stuff that we've alluded to before which is around evidence they actually talk about in the PBAC summary, in particular, that the PBAC considered the claim that micronized progesterone has a lower breast cancer risk compared to mediproxen acetate, mpa, which we have also talked about, was uncertain.
00:07:08.370 --> 00:07:18.648
So again it comes back to you know we keep coming back to there's a lack of good, robust clinical evidence with so much around these drugs and women's bodies and women's healthcare.
00:07:18.648 --> 00:07:25.922
What that indicates is that there's more advocacy to be done on research, which we're going to get to shortly.
00:07:25.922 --> 00:07:29.942
Yeah, now we've got to watch this space to see if and when these products make it onto the PBS.
00:07:30.322 --> 00:07:34.273
Yeah, and so we would expect an announcement, obviously sometime this year.
00:07:34.273 --> 00:07:42.963
We're only at the start of this year, but we will absolutely keep you updated on any movement in that space and anything that we hear in regards to the outcome on that.
00:07:42.963 --> 00:07:45.507
So great news, but still a little way to go.
00:07:45.507 --> 00:07:47.471
All right, let's move on to now.
00:07:47.471 --> 00:08:09.685
I'm going to take over the controls here for a moment, and I would like us to cover the announcement that I made a couple of weeks ago that I am now the freshly minted and very first ambassador to Australia and New Zealand for menopause and cancer, which is a UK space charity.
00:08:10.165 --> 00:08:15.598
I have been in conversation with them for gosh well over 12 months now.
00:08:15.598 --> 00:08:25.850
I first met Dani Binnington, who's the founder right here on Dear Menopause, when she agreed to be interviewed, and we've kept our lines of communication open.
00:08:25.850 --> 00:08:34.984
Towards the end of last year, I reached out and said hey, look, we really have a need for services that you are already offering so successfully in the UK.
00:08:34.984 --> 00:08:46.447
Here in Australia and New Zealand, I would love to be a part of that, and so I have joined the Menopause and Cancer UK team as their ambassador across Australia and New Zealand, which is really exciting.
00:08:46.447 --> 00:08:49.169
These are services that have not been offered in Australia, and New.
00:08:49.190 --> 00:08:59.451
Zealand before to women that have experienced menopause as a result of cancer, and there are many cancers that can actually lead to menopause.
00:08:59.451 --> 00:09:00.931
It's not just breast cancer.
00:09:00.931 --> 00:09:05.667
Often we kind of think that it is because it's probably the most popular and highly talked about.
00:09:05.667 --> 00:09:12.222
But you know we have to factor into that women that are impacted by gynecological cancers.
00:09:12.222 --> 00:09:17.825
A lot of blood cancers can also the medications and treatments for that lead to a menopause as well.
00:09:17.825 --> 00:09:26.448
So this is a very holistic organization that takes into account anybody in the community that has been impacted by menopause and cancer.
00:09:26.448 --> 00:09:28.259
So that is an exciting announcement.
00:09:28.279 --> 00:09:29.081
This is really.
00:09:29.423 --> 00:09:34.023
I mean, sonia, this is so exciting because I think this could not have happened at a better time.
00:09:34.364 --> 00:10:05.801
When you think about, you know, so many of the submissions that we saw in the Senate inquiry last year, the fact that you know we have a number of recommendations, the fact that you're going to take on this role now, at this point, when there is, I guess, still quite a lot of advocacy to do to make sure that those recommendations become reality, means it could not be a better time for that you know quite significant cohort of women who experience menopause as a result of cancer and cancer treatment, to make sure that those voices are heard.
00:10:06.182 --> 00:10:21.726
But I think also, I think what's going to be really critical in this process is hopefully, you know, maybe we move towards some national guidelines around you know, menopause treatment and care is ensuring that those voices and the treatment protocols for people who have suffered from cancer get included.
00:10:21.726 --> 00:10:32.725
Because what I keep seeing I keep seeing, I mean probably almost daily on my social is women who are talking about how their medical professionals in their care after cancer don't talk about menopause.
00:10:32.725 --> 00:10:40.283
It's not really factored in, which really surprised me, given it's well, now it's 2025.
00:10:40.485 --> 00:10:42.928
Yeah, oh, I know it's absolutely disgraceful.
00:10:42.928 --> 00:11:13.690
One of the reasons I just reached across and grabbed my pad and paper was I was having a conversation with Danny during the week earlier in the week, and we were talking about some of the stats and data that we can extrapolate across here to our community that they have gained from their community in the UK, and they surveyed their community and 90.4% of their community came back and said that they had received zero help when it came to their menopause as a result of cancer.
00:11:14.480 --> 00:11:16.942
Not 94%, four that's.
00:11:16.942 --> 00:11:33.231
I mean, that's quite hard to get your head around that you're talking about women, and something that's so inherently important is you know how we, how we live in our bodies and how we function, and you know thinking about whether you you know might want children or have children, or you know.
00:11:33.231 --> 00:11:36.767
To not have that discussion just seems well.
00:11:36.767 --> 00:11:39.081
It seems like, sonia, you're going to have your work cut out.
00:11:39.883 --> 00:11:40.423
It does.
00:11:40.423 --> 00:11:54.033
I know Dani and I were going back and forward on something over the weekend and you know she asked me a question about where, if you are in cancer treatment here and you've experienced menopause as a result, like who within your team do you reach out to for support?
00:11:54.033 --> 00:11:58.951
And so you know I kind of answered that and then she was like okay, now I want to know how likely they are to get that support.
00:11:58.951 --> 00:12:01.283
And then I did this big dump.
00:12:01.283 --> 00:12:06.256
Basically, it comes down to in many respects being a postcode lottery of you know.
00:12:06.256 --> 00:12:07.440
Do you live in the city versus?
00:12:07.440 --> 00:12:08.224
Are you regional?
00:12:08.224 --> 00:12:08.966
Are you rural?
00:12:08.966 --> 00:12:09.971
Are you public patient?
00:12:09.971 --> 00:12:10.976
Are you a private patient?
00:12:10.976 --> 00:12:15.778
What budget do you have available to you to spend on specialists outside of the cancer care?
00:12:15.778 --> 00:12:17.423
You're already getting so many things.
00:12:17.464 --> 00:12:44.325
And then my last sentence to her was we have so much work to do thinking about that, yes, but in terms of looking for the silver lining, now is the is the most optimum time to be having that, because we know that the government is thinking about what they're going to do in this space and we also have an election coming up, so that, I think, is a really good point in terms of the advocacy that you're going to be able to do in this role, which is also one of the other things we wanted to talk about it was.
00:12:44.404 --> 00:12:47.032
But before we jump, I just want to also just finish up with.
00:12:47.032 --> 00:12:50.749
You know my role here is not going to be just advocacy.
00:12:50.749 --> 00:12:52.120
Advocacy is going to be a big part of it.
00:12:52.120 --> 00:12:53.423
That's a big part of who I am.
00:12:53.423 --> 00:13:10.908
But what is most exciting to me is we will be bringing the services that the UK deliver now to the community, which are educational and awareness raising, in person, online, and, you know, we'll create a community network across Australia and New Zealand.
00:13:11.029 --> 00:13:14.846
I've already had so many community members reach out to me saying how can I help?
00:13:14.846 --> 00:13:16.152
This is where I live.
00:13:16.152 --> 00:13:24.384
So you know we're going to be organizing coffee mornings where people can get together and have a conversation with someone that's experienced exactly what you're experiencing.
00:13:24.384 --> 00:13:27.568
We've got a huge global Facebook community already.
00:13:27.568 --> 00:13:29.052
We won't be creating anything new.
00:13:29.052 --> 00:13:34.533
We'll just be folding everybody into that one, because the issues that everybody faces are the same.
00:13:34.533 --> 00:13:43.011
It doesn't matter where you're situated or based, and there's a brilliant community in there that is always jumping in and answering everyone's questions and providing support when people need it.
00:13:43.011 --> 00:13:52.649
So, yes, advocacy is going to be a part of it, but there's also going to be a huge part of providing support and community and education and access to experts as well.
00:13:52.649 --> 00:13:58.566
That's a part of the workshops we'll be running, and we'll be announcing all of that very, very soon, so that people will know what to expect.
00:13:58.566 --> 00:13:59.048
So that's it.
00:13:59.048 --> 00:14:00.866
I have wrapped up my pitch.
00:14:01.280 --> 00:14:10.206
That was what I wanted to say I think you're going to probably be inundated with, you know, people wanting a guidance.
00:14:10.206 --> 00:14:14.004
In a way it's you're probably going to need, yeah, like a, like a pathway of like where to go for information and who to see.
00:14:14.004 --> 00:14:33.990
And I mean, I already know, like even from the in the menopause space over the last couple of years, I still get contacted by people saying can you recommend any good doctors in, you know, new south wales or the hunger for detailed information is huge and because you're filling a massive void in Australia, you'll be prepared to be busy.
00:14:35.152 --> 00:14:38.667
I am prepared to be busy and excited to be as well.
00:14:38.667 --> 00:14:45.647
All right, so let's move now on to the next topic that we're going to talk about, and that is advocacy.
00:14:45.647 --> 00:14:47.880
Jo, you brought this to my attention.
00:14:47.880 --> 00:14:54.846
I hadn't seen it until you brought it to my attention, so why don't you do a quick spiel about this amazing guide?
00:14:55.126 --> 00:14:55.347
Yes.
00:14:55.347 --> 00:15:03.605
So I saw this on one of the global medical professionals whose Instagram I follow, mary Claire Haver.
00:15:03.605 --> 00:15:16.764
It's called A Citizen's Guide to Menopause Advocacy Simple Steps for Transformative Change, and it is brilliant.
00:15:16.764 --> 00:15:26.227
So Dr Mary-Claire has worked with a couple of other people and developed some steps which help the individual, the person on the street, have a better understanding of how they can advocate in this space.
00:15:26.489 --> 00:15:29.274
One of the things on the front there's like a little snapshot of it.
00:15:29.274 --> 00:15:53.587
It looks like a text message or a note, and I just really love it because it says, with the advent of social media, the flow of information has been democratised, and I think that's one of the things that excites me the most about living in this age with all of the social media, that it is possible to create a community and drive change without ever happening to meet anyone in person.
00:15:53.587 --> 00:16:06.707
This Citizen's Guide to Menopause Advocacy it has an incredible foreword by Maria Shriver which just you know it just made my heart sing.
00:16:06.707 --> 00:16:07.711
It also made me go.
00:16:07.711 --> 00:16:16.224
I want a journalist like that in Australia to, you know, kind of take this movement and do similar things.
00:16:16.224 --> 00:16:17.466
It was really powerful.
00:16:17.466 --> 00:16:32.849
But the other key thing is it then lists its policy goals and gives examples of how to achieve them, and the thing that struck me reading it, sonia, was the policy goals are pretty much the same as the policy goals that we would like to achieve here.
00:16:33.100 --> 00:16:35.008
That was my exact thought.
00:16:35.008 --> 00:16:36.466
Like I jumped into it.
00:16:36.466 --> 00:16:38.708
It's an online downloadable PDF.
00:16:38.708 --> 00:16:40.025
It doesn't cost you anything.
00:16:40.025 --> 00:16:41.505
It's 37 pages.
00:16:41.505 --> 00:16:46.169
I've got it open on my computer right now Super accessible, jam-packed with information.
00:16:46.169 --> 00:16:48.043
But that's the first thought that I had.
00:16:48.043 --> 00:16:59.293
As soon as I scrolled to the table of contents, I was like, oh my gosh, but how good is it that, globally, without collaboration, we are all on the same page.
00:17:00.279 --> 00:17:02.504
I know that's exactly what struck me.
00:17:02.504 --> 00:17:05.888
In fact I was like, oh, this is quite similar to.
00:17:05.888 --> 00:17:16.355
You know some of the policy goals that we had put together, a group of us, a consortium of us put together in a budget submission to the Australian government just over 12 months ago.
00:17:16.355 --> 00:17:19.424
But very quickly, I thought I'd just read them out, so you've got you know.
00:17:19.424 --> 00:17:23.442
Policy goal one reset the record about menopause hormone treatment Yep.
00:17:23.442 --> 00:17:27.712
Policy goal two catalyze a modern, equitable menopause research agenda.
00:17:28.380 --> 00:17:28.681
Yes.
00:17:29.342 --> 00:17:33.852
Policy goal three update and mandate menopause education for providers.
00:17:33.852 --> 00:17:34.820
That one's needed.
00:17:34.820 --> 00:17:38.229
Policy goal four make menopause treatments affordable.
00:17:38.229 --> 00:17:39.732
Well, we've just talked about that.
00:17:39.732 --> 00:17:46.010
Policy goal five make menopause treatments free of outdated warning labels.
00:17:46.010 --> 00:17:47.574
We've also spoken about that.
00:17:47.574 --> 00:17:51.691
And policy goal six ensure meaningful workplace interventions.
00:17:51.691 --> 00:17:59.446
I mean these are pretty much also reflected in the Senate inquiries recommendations and they're all really doable.
00:17:59.446 --> 00:18:02.400
Yeah, which is also exciting.
00:18:02.400 --> 00:18:03.743
You don't read them and go.
00:18:03.743 --> 00:18:05.809
That's never going to be achieved.
00:18:05.809 --> 00:18:08.195
No, exciting, you don't read them and go.
00:18:08.217 --> 00:18:09.359
That's never going to be achieved.
00:18:09.359 --> 00:18:16.932
No, and what I love is that then, after for each of those policy goals, they give a little one pager, if you like, that has a take action kind of call to action on it.
00:18:16.932 --> 00:18:18.601
So this is what you can do Now.
00:18:18.601 --> 00:18:28.127
Do keep in mind this is written from an American perspective, so there is a lot of American links and referring to American organizations.
00:18:28.127 --> 00:18:31.843
I was like we need an australian version of this.
00:18:31.843 --> 00:18:34.791
That's exactly what I thought too.
00:18:34.832 --> 00:18:39.483
Sonia hello, anybody wanting to fund us to put that together, reach out.
00:18:39.483 --> 00:18:42.049
But yeah, so do just go into it.
00:18:42.049 --> 00:18:51.624
If you do download this and have a little think about you know where you can actually use some of this information and just translate that into you know what exists here in Australia, because an equivalent will exist.
00:18:51.624 --> 00:19:02.261
And until we do get the opportunity to update this for Australia, it would be amazing to just for you to work out who it is in Australia that takes the place of the American body that they refer to.
00:19:02.261 --> 00:19:05.347
But great, recommended action steps.
00:19:05.347 --> 00:19:14.491
How to do that, as just somebody in the public that's invested in seeing a change in this narrative and in this situation that we find ourselves in?
00:19:15.140 --> 00:19:23.208
And I think you know I often also see in social media, I mean all the time actually, you know people commenting and saying what can I do to help?
00:19:23.208 --> 00:19:29.770
How can we get this on the agenda, you know, and so this is actually quite a great tool, and is it the kind of thing you could link in the show notes?
00:19:31.099 --> 00:19:31.882
Sure, good question.
00:19:31.882 --> 00:19:34.346
It absolutely is Wonderful.
00:19:34.346 --> 00:19:40.880
So yeah, I will definitely have a link to this in the show notes and, as I said, it's literally just a PDF download.
00:19:41.201 --> 00:19:45.249
And I think it's you know I would love to see an Australian version.
00:19:45.249 --> 00:19:47.133
So yes, let's see if we can.
00:19:47.133 --> 00:19:50.386
You know if someone would like to generate such a document.
00:19:50.386 --> 00:20:05.788
But one of the other things that did make me think, like in terms of the Senate inquiry and I did want to this kind of wraps in really nicely, sonia is we were hoping to hear from the government, I think on the 18th of December, to respond to the Senate inquiry recommendation.
00:20:05.788 --> 00:20:13.507
So the government originally, after any Senate inquiry is tabled, they have three months to respond.
00:20:13.507 --> 00:20:18.605
Unfortunately, the Albanese government has not yet responded, which is really disappointing.
00:20:18.605 --> 00:20:22.306
I'm going to give them the benefit of the doubt and go with.
00:20:22.306 --> 00:20:31.311
It's because they're so busy coming up with how they're going to implement all the recommendations that they want to make sure they've gotten it all right before they respond.
00:20:32.099 --> 00:20:42.381
That's a great way to look at it, jo, but you know I've been inundated with messages from people actually going hey, just wondering, did I miss the announcement about the Senate inquiry report?
00:20:42.381 --> 00:20:44.586
And I'm like, no, sorry, you didn't.
00:20:44.586 --> 00:20:46.089
It's just not come down yet.
00:20:46.089 --> 00:20:47.112
So, yes, we're waiting.
00:20:47.112 --> 00:20:55.183
If you're listening and you are at all in control around this, please know that we are waiting with bated breath there's a lot of women.
00:20:55.304 --> 00:21:01.606
There's a lot of women waiting for the answers on this and uh, now, what was my train of thought with that?
00:21:01.606 --> 00:21:06.483
It was so, in terms of advocacy around that, one of the things that you know I'm I'm now thinking about.
00:21:06.483 --> 00:21:10.371
Well, what can we do to ensure that this doesn't just?
00:21:10.371 --> 00:21:12.454
You know there's an election looming.
00:21:12.454 --> 00:21:15.125
We don't want this to drop off the government's agenda or to go.
00:21:15.125 --> 00:21:20.729
We're about to go into an election, this isn't a priority and then it disappears and you know there could be a change of government.
00:21:20.729 --> 00:21:26.355
We want some action before we go into this election phase, before we go into this election phase.
00:21:26.859 --> 00:21:28.124
So you know, thinking about what you could do if you were listening.
00:21:28.124 --> 00:21:33.588
You know there are some simple things like write to your local member and say I was following the Senate inquiry.
00:21:33.588 --> 00:21:36.528
My understanding was the government was due to respond.
00:21:36.528 --> 00:21:38.647
Could you advise me as to where that's up to?
00:21:38.647 --> 00:21:48.862
If your local member is not a Labor member of parliament, well then you could put it onto the coalition or the Greens agenda and say could you follow this up for me?
00:21:48.862 --> 00:21:51.086
What is your party's response?
00:21:51.086 --> 00:21:51.386
Now?
00:21:51.386 --> 00:21:59.261
The Greens, we know already did have responded to the recommendations, but we haven't heard anything from the National Party, the Liberal Party or the Labor Party at this point.
00:21:59.261 --> 00:22:16.685
So you know you can write and ensure that your elected representative knows that this is important to you and if you think about how many menopausal women there are, if we all wrote that would be quite a lot of correspondence and would also make them realise that this is something that is relevant coming into an election.
00:22:16.886 --> 00:22:21.069
Yeah, hugely relevant and we hold 51% of the vote.
00:22:21.940 --> 00:22:22.984
Yeah, that's pretty amazing.
00:22:22.984 --> 00:22:35.611
So, and I think you know, I think the amount of women that are actually in the menopause transition is about 3 million, but it's even bigger if you kind of you take it outside the kind of traditional age that is considered menopause.
00:22:35.611 --> 00:22:39.170
So that's a, that's a lot of women with a lot of voting power.
00:22:39.980 --> 00:22:40.500
Yeah, we do.
00:22:40.500 --> 00:22:48.102
We hold a lot of power and we need to really lean into that for want of a better expression, and start, you know, using our voices.
00:22:48.825 --> 00:22:59.345
Yeah, and you know, one of the other things I had seen over the summer break not that I was spending a lot of time on the socials, but I don't know if you saw it, sonia was Dr Louise Newsom had some research published.
00:22:59.345 --> 00:23:01.208
She did, yeah, so it was a team of you know doctors and researchers.
00:23:01.228 --> 00:23:02.770
I know Rebecca was also involved, who works closely with Louise.
00:23:02.770 --> 00:23:03.813
There's a big team of um.
00:23:03.813 --> 00:23:05.035
You know doctors and researchers.
00:23:05.035 --> 00:23:08.501
I know rebecca was also involved, um, who works closely with louise.
00:23:08.501 --> 00:23:09.605
There's a big team of them.
00:23:09.605 --> 00:23:13.662
But yes, there was a fantastic paper published on the um.
00:23:14.502 --> 00:23:21.095
It was all around the absorption of estrogen yes, um, and I'm just trying to find it.
00:23:21.641 --> 00:23:25.048
I had it open before so I've got it open here.
00:23:25.048 --> 00:23:41.010
So the aim of the study was to explore the range and variation in serum estradiol concentration and to estimate the prevalence of quotations, poor absorption in perimenopausal and post-men or women using transdermal estradiol in the real world.
00:23:41.010 --> 00:23:56.832
So, yeah, this was really interesting because if you closely follow this conversation, you will know that there has been some talk, some very loud talk, around the overprescription, particularly of estrogen.
00:23:56.832 --> 00:23:57.873
Is it a good thing?
00:23:57.873 --> 00:23:58.794
Should it be happening?
00:23:58.794 --> 00:23:59.575
What does it mean?
00:23:59.575 --> 00:24:00.596
Why do they do it?
00:24:00.596 --> 00:24:02.278
Is it off-label, is it on-label?
00:24:02.278 --> 00:24:03.403
Why, you know.
00:24:03.403 --> 00:24:20.016
And so this paper really addressed and the outcome of it really showed that every single woman or person that uses transdermal estrogen, whether that's a patch or a gel, but I think this was predominantly done on patches Is that right?
00:24:20.016 --> 00:24:21.563
I think?
00:24:21.563 --> 00:24:27.250
It was all I think it was all it was all Okay, cool, do absorb at very, very different rates.
00:24:27.539 --> 00:24:49.463
Yes, and what I think is really interesting about this is, you know, there has been a lot of grumbling, I think, or outright not very you know unpleasantness over the last 12 months and, you know, frankly, a bit of a witch hunt against Dr Louise Newsome by some in the menopause space around the fact that she is prescribing outside the recommended doses.
00:24:49.463 --> 00:25:07.471
A lot of doctors have come out and been quite vocal about the fact that actually they prescribe outside the recommended doses because of this exact issue, when they actually test levels that they find that women aren't absorbing, and the conclusions of this paper actually talked about that.
00:25:07.471 --> 00:25:12.863
There is considerable inter-individual variation, and I think what this means is.
00:25:12.863 --> 00:25:25.190
It does come back to individualised care, and I noticed that Professor Kulkarni was recently quoted saying that it's important to focus on patient care, not ideologies.
00:25:25.190 --> 00:25:34.163
Evidence from scientific clinical trials is important, but so is the art of medicine, which is all about clinical experience, listening and providing compassionate care.
00:25:34.163 --> 00:25:51.194
I think that really lies in this example as well, and one of the other things that really struck me, because it was reflected in Australia, is Dr Kelly Teagle, who runs WellFem, which is Australia's first and largest telehealth clinic, which is just for menopausal care.
00:25:51.194 --> 00:26:03.711
Kelly founded WellFem five years ago, so she was at the forefront of this movement long before anybody else and, as a GP, had realized that there was this massive gap that was happening for midlife women.
00:26:03.711 --> 00:26:14.539
She actually did a post three months ago on this exact issue and she was saying that you know, all she sees is menopausal women.
00:26:14.539 --> 00:26:16.986
That is her sole client base.